Business Description
Unipharma Co Ltd
ISIN : TW0006621006
Description
Unipharma Co Ltd is a medical diagnostic, pharmaceutical and medical device company. It is engaged in developing drug products and medical equipment. The company's products offerings include Baxter, Tambocor tablets, Bain Injection, Esmolol HCL Injection, Naloxone Injection, and SAM Pelvic Sling medical device. Its customers are major medical centers, regional hospitals, regional hospitals, and clinics.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.71 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.84 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 8.52 | |||||
| Beneish M-Score | -3.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.6 | |||||
| 3-Year EBITDA Growth Rate | 28.5 | |||||
| 3-Year EPS without NRI Growth Rate | 27 | |||||
| 3-Year Book Growth Rate | -6.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.88 | |||||
| 9-Day RSI | 48.95 | |||||
| 14-Day RSI | 49.01 | |||||
| 6-1 Month Momentum % | 8.54 | |||||
| 12-1 Month Momentum % | -14.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.05 | |||||
| Quick Ratio | 9.65 | |||||
| Cash Ratio | 8.4 | |||||
| Days Inventory | 193.2 | |||||
| Days Sales Outstanding | 71.81 | |||||
| Days Payable | 85.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | -1.14 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.09 | |||||
| Operating Margin % | -32.12 | |||||
| Net Margin % | -26.55 | |||||
| FCF Margin % | -27.5 | |||||
| ROE % | -8.54 | |||||
| ROA % | -7.74 | |||||
| ROIC % | -20.91 | |||||
| ROC (Joel Greenblatt) % | -65.28 | |||||
| ROCE % | -8.4 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 52.99 | |||||
| PS Ratio | 4.99 | |||||
| PB Ratio | 1.63 | |||||
| Price-to-Tangible-Book | 1.63 | |||||
| EV-to-EBIT | -13.98 | |||||
| EV-to-EBITDA | -18.51 | |||||
| EV-to-Revenue | 3.72 | |||||
| EV-to-FCF | -13.73 | |||||
| Price-to-Projected-FCF | 2.95 | |||||
| Price-to-Net-Current-Asset-Value | 3.1 | |||||
| Price-to-Net-Cash | 4.33 | |||||
| Earnings Yield (Greenblatt) % | -7.16 | |||||
| FCF Yield % | -5.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Unipharma Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 99.557 | ||
| EPS (TTM) (NT$) | -0.74 | ||
| Beta | 0.26 | ||
| Volatility % | 37.72 | ||
| 14-Day RSI | 49.01 | ||
| 14-Day ATR (NT$) | 0.400923 | ||
| 20-Day SMA (NT$) | 14.185 | ||
| 12-1 Month Momentum % | -14.42 | ||
| 52-Week Range (NT$) | 11.8 - 19.65 | ||
| Shares Outstanding (Mil) | 35.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Unipharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Unipharma Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Unipharma Co Ltd Frequently Asked Questions
What is Unipharma Co Ltd(ROCO:6621)'s stock price today?
The current price of ROCO:6621 is NT$14.00. The 52 week high of ROCO:6621 is NT$19.65 and 52 week low is NT$11.80.
When is next earnings date of Unipharma Co Ltd(ROCO:6621)?
The next earnings date of Unipharma Co Ltd(ROCO:6621) is .
Does Unipharma Co Ltd(ROCO:6621) pay dividends? If so, how much?
Unipharma Co Ltd(ROCO:6621) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers